Allogene Therapeutics, Inc. (ALLO)
2.03
-0.06
(-2.87%)
USD |
NASDAQ |
Aug 24, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Price : 2.03 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 2.11 | 2.11 | 2.00 | 2.03 | 4.756M |
| Aug 21, 2026 | 2.12 | 2.15 | 2.06 | 2.09 | 4.373M |
| Aug 20, 2026 | 2.19 | 2.21 | 2.07 | 2.10 | 4.861M |
| Aug 19, 2026 | 2.08 | 2.23 | 2.08 | 2.23 | 6.715M |
| Aug 18, 2026 | 2.07 | 2.085 | 2.00 | 2.03 | 4.089M |
| Aug 17, 2026 | 2.05 | 2.10 | 2.02 | 2.08 | 4.677M |
| Aug 14, 2026 | 1.96 | 2.08 | 1.92 | 2.05 | 4.605M |
| Aug 13, 2026 | 2.13 | 2.16 | 1.955 | 1.98 | 6.336M |
| Aug 12, 2026 | 2.13 | 2.145 | 2.045 | 2.07 | 4.578M |
| Aug 11, 2026 | 2.11 | 2.19 | 2.065 | 2.12 | 4.967M |
| Aug 10, 2026 | 1.99 | 2.10 | 1.978 | 2.10 | 5.360M |
| Aug 07, 2026 | 1.98 | 2.025 | 1.959 | 2.01 | 3.699M |
| Aug 06, 2026 | 1.95 | 1.99 | 1.92 | 1.97 | 3.170M |
| Aug 05, 2026 | 1.90 | 1.98 | 1.90 | 1.95 | 5.056M |
| Aug 04, 2026 | 1.87 | 1.91 | 1.82 | 1.90 | 4.997M |
| Aug 03, 2026 | 1.87 | 1.90 | 1.81 | 1.84 | 7.040M |
| Jul 31, 2026 | 1.97 | 2.00 | 1.86 | 1.88 | 5.522M |
| Jul 30, 2026 | 1.86 | 2.00 | 1.855 | 1.97 | 10.52M |
| Jul 29, 2026 | 1.72 | 1.88 | 1.65 | 1.81 | 12.52M |
| Jul 28, 2026 | 1.75 | 1.76 | 1.61 | 1.66 | 9.960M |
| Jul 27, 2026 | 1.80 | 1.910 | 1.75 | 1.75 | 6.901M |
| Jul 24, 2026 | 1.83 | 1.84 | 1.74 | 1.74 | 4.874M |
| Jul 23, 2026 | 1.82 | 1.85 | 1.78 | 1.82 | 5.640M |
| Jul 22, 2026 | 1.84 | 1.88 | 1.825 | 1.86 | 4.135M |
| Jul 21, 2026 | 1.76 | 1.85 | 1.76 | 1.85 | 4.490M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cartesian Therapeutics, Inc. | 10.06 |
| Beam Therapeutics, Inc. | 28.33 |
| Kyverna Therapeutics, Inc. | 8.24 |
| Arrowhead Pharmaceuticals, Inc. | 86.73 |
| Oncolytics Biotech, Inc. | 0.8441 |
Price Related Metrics
| PS Ratio | 111.27 |
| Price to Book Value | 1.607 |
| Earnings Yield | -32.76% |
| Market Cap | 701.05M |